Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior

American Journal of Pathology

Volumn 150, Issue 2, 1997, Pages 483-495

  Hendrix, Mary J C ^a   Seftor, Elisabeth A ^a   Seftor, Richard E B ^a   Trevor, Katrina T ^b  

^a UNIVERSITY OF IOWA   (United States)

^b ST LUKE S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; INTEGRIN; INTERMEDIATE FILAMENT PROTEIN; KERATIN; LAMININ RECEPTOR; VIMENTIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER INVASION; CELL DIFFERENTIATION; CELL INVASION; CELL MOTILITY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; INTERMEDIATE FILAMENT; LYMPH NODE METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCID MOUSE; SIGNAL TRANSDUCTION;

ANIMALS; BREAST NEOPLASMS; CELL MEMBRANE; COLONY-FORMING UNITS ASSAY; HUMANS; INTEGRINS; KERATINS; MICE; MICE, SCID; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PHENOTYPE; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; VIMENTIN;

EID: 0031016323     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Boring CC, Squires TS,Tong T: Cancer statistics, 1993. Cancer J Clin 1993, 20:7-26
2. Osborn M, Weber K: Intermediate filaments: cell-typespecific markers in differentiation and pathology. Cell 1982, 31:303-306
3. Raymond WA, Leong AS-Y: Vimentin: a new prognostic parameter in breast carcinoma? J Pathol 1989, 158: 107-114
4. Domagala W, Lasota J, Bartowiak J, Weber K, Osborn M: Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction, Am J Pathol 1990, 136:219-227
5. Domagala W, Leszek W, Lasota J, Weber K, Osborn M: Vimentin is preferentially expressed in high-grade ductal and medullary but not in lobular breast carcinomas, Am J Pathol 1990, 137:1059-1064
6. Thompson EW, Paik S, Brunner N, Sommers CL, Zugmaier G, Clarke R, Shima TB, Torri j, Donahue S, Lippman ME, Martin GR, Dickson RB: Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 1992, 150:534-544
7. Sommers CL, Heckford SE, Skerker JM, Worland P, Torri JA, Thompson EW, Byers SW, Gelmann EP: Loss of epithelial markers and acquisition of vimentin expression in adriamycin-and vinblastine-resistant human breast cancer cell lines. Cancer Res 1992, 52: 5190-5197
8. Sommers CL, Walker-Jones D, Heckford SE, Worland P, Valverius E, Clark R, Stampfer M, Gelmann EP: Vimentin rather than keratin expression in some hormone-independent breast cancer cell lines in oncogene-transformed mammary epithelial cells, Cancer Res 1989, 49:4258-4263
9. McLean WHI, Lane EB: Intermediate filaments in disease. Curr Opin Cell Biol 1995, 7:118-125
10. Fuchs E, Weber K: Intermediate filaments: structure, dynamics, function, and disease, Annu Rev Biochem 1994, 63:345-382
11. Klymkowsky MW: Intermediate filaments: new proteins, some answers, more questions. Curr Opin Cell Biol 1995. 7:46-54
12. Steinert PM, Liem RK: Intermediate filament dynamics. Cell 1990, 60:521-523
13. Skalli O, Goldman RD: Recent insights into the assembly, dynamics, and function of intermediate filament networks, Cell Motil Cytoskel 1991, 19:67-79
14. Stewart M: Intermediate filaments: structure, assembly, and molecular interactions. Curr Opin Cell Biol 1994, 12:91-100
15. Oshima RG: Intermediate filament molecular biology. Curr Opin Cell Biol 1992, 4:110-116
16. Oshima RG, Howe WE, Klier FG, Adamson ED, Shevinsky LH: Intermediate filament protein synthesis in preimplantation murine embryos, Dev Biol 1983, 99:447-455
17. Duprey P, Morello D, Vasseu M, Babinet C, Condamine H, Brulet P, Jacob F: Expression of the cytokeratin endo A gene during early mouse embryogenesis, Proc Natl Acad Sci USA 1985, 82:8535-8539
18. Lane EB, Hogan BLM, Kurkinen M, Garrels JI: Coexpression of vimentin and cytokeratins in parietal endoderm cells of the early mouse embryo. Nature 1983,303:701-703
19. Rosen EM, Nigam SK, Goldberg ID: Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction. J Cell Biol 1994, 127:1783-1787
20. Fuchs E: Intermediate filaments and disease: mutations that cripple cell strength. J Cell Biol 1994, 125: 511-516
21. Sarria AJ, Nordeen SK, Evans RM: Regulated expression of vimentin cDNA in cells in the presence and absence of a preexisting vimentin filament network. J Cell Biol 1990, 111:553-565
22. Trevor KT: Disruption of keratin filaments in embryonic epithelial cell types. New Biol 1990, 2:1004-1014
23. Gunning P, Leavitt J, Muscat G, Ng S-Y, Kedes L: A human β-actin expression vector system directs high level accumulation of antisense transcripts. Proc Natl Acad Sci USA 1987, 84:4831-4835
24. Gorman CM, Merlino GT, Willingham MC, Pastan I, Howard BH: The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection. Proc Natl Acad Sci USA 1982, 79:6777-6781
25. Hendrix MJC, Seftor EA, Seftor REB, Fidler IJ: A simple quantitative assay for studying the invasive potential of high and low human metastatic variants. Cancer Lett 1987, 38:137-147
26. McCarthy JB, Palm SL, Furcht LT; Migration by haptotaxis of a Schwann cell tumor cell line to the basement membrane glycoprotein laminin, J Cell Biol 1983, 97: 772-777
27. Hamburger AW, Salmon SE: Primary bioassay of human tumor stem cells. Science 1977, 197:461-463
28. Stetler-Stevenson WG, Aznavoorian S, Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993, 9:541-573
29. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991, 64:327-336
30. Kohn EC, Liotta LA: Molecular insights into cancer invasion: strategies for prevention and interventions, Cancer Res 1995, 55:1856-1862
31. Chu Y-W, Runyan RB, Oshima RG, Hendrix MJC: Expression of complete keratin filaments in mouse L cells augments cell migration and invasion. Proc Natl Acad Sci USA 1993, 90:4261-4265
32. Andreoli JM, Trevor KT: Structural and biological consequences of increased vimentin expression in simple epithelial cell types, Cell Motil Cytoskel 1995, 32:10-25
33. Hendrix MJC, Seftor EA, Chu Y-W, Seftor REB, Nagle RB, McDaniel KM, Leong SPL, Yohem KH, Leibovitz AM, Meyskens FL Jr, Conaway DH, Welch DR, Liotta LA, Stetler-Stevenson WG: Coexpression of vimentin and keratins by human melanoma tumor cells: correlation with invasive and metastatic potential, J Natl Cancer Inst 1992, 84:165-174
34. Bauman PA, Dalton WS, Anderson JM, Cress AE: Expression of cytokeratin confers multiple drug resistance. Proc Natl Acad Sci USA 1994, 91:5311-5314
35. Potts JD, Dagle JM, Walder JA, Weeks DL, Runyan RB: Epithelial-mesenchymal transformation of embryonic cardiac endothelial cells is inhibited by a modified antisense oligodeoxynucleotide to transforming growth factor β3. Proc Natl Acad Sci USA 1991,88:1516-1520
36. Shea TB, Beermann ML, Fischer I: Transient requirement for vimentin in neuritogenesis: intracellular delivery of anti-vimentin antibodies and antisense oligonucleotides inhibit neurite initiation but not elongation of existing neuntes in neuroblastoma. J Neurosci Res 1993, 36:66-76
37. Lichtner RB, Julian JA, North SM, Glasser SR, Nicolson GL Coexpression of cytokeratins characteristic for myoepithelial and luminal cell lineages in rat 13762NF mammary adenocarcinoma tumors and their spontaneous metastases, Cancer Res 1991, 51:5943-5950
38. Stover DM, Carey I, Garzon RJ, Zehner ZE: A negative regulatory factor is missing in a human metastatic breast cancer cell line. Cancer Res 1994, 54:3092-3095
39. Chu Y-W, Seftor EA, Romer LH, Hendrix MJC: Experimental Coexpression of vimentin and keratin intermediate filaments in human melanoma cells augments motility. Am J Pathol 1996, 148:63-69
40. Griffith CM, Hay ED: Epithelial-mesenchymal transformation during palatal fusion: carboxyfluorescein traces cells at light and electron microscopic levels. Development 1992, 116:1087-1099
41. Steuli CH, Bissell MJ: Mammary epithelial cells, extracellular matrix, and gene expression. Cancer Treat Res 1991, 53:365-381
42. Juliano RL, Haskill S: Signal transduction from the extracellular matrix. J Cell Biol 1993, 120:577-585
43. Ginsberg MH, Du X, Plow EF: Inside-out integrin signaling. Curr Opin Cell Biol 1992, 4:766-771
44. Ingber D: Integrins as mechanochemical transducers. Curr Opin Cell Biol 1991, 3:841-848
45. Miyamoto S, Teramoto H, Coso OA, Gutkind JS, Burbelo PD, Akiyama SK, Yamada KM: Integrin function: Molecular hierarchies of cytoskeletal and signaling molecules. J Cell Biol 1995, 131:791-805
46. Albelda SM, Buck CA: Integrins and other cell adhesion molecules. FASEB J 1990, 4:2868-2880
47. Ruoslahti E: Integrins. J Clin Invest 1991, 87:1-5
48. Kobota S, Tashiro K, Yamada Y: Signaling site of laminin with mitogenic activity, J Biol Chem 1992, 257: 4285-4288
49. 1 integrin abrogates the malignant phenotype of breast carcinoma cells, Proc Natl Acad Sci USA 1995, 92:7411-7415
50. Quaranta V, Jones JCR: The internal affairs of an integrin. Trends Cell Biol 1991, 1:2-4
51. Wayner EA, Orlando RA, Cheresh DA: Integrins αvβ3 and αvβ5 contribute to cell attachment to vitronectin but differentially distribute on the cell surface, J Cell Biol 1991, 113:919-929
52. Tawil N. Wilson P, Carbonetto S: Integrins in point contacts mediate spreading, J Cell Biol 1993, 120:261-271
53. Seftor REB, Seftor EA, Gehlsen KR, Stetler-Stevenson WG, Brown PD, Ruoslahti E, Hendrix MJC: Role of the αvβ3 integrin in human melanoma cell invasion, Proc Natl Acad Sci USA 1992, 89:1557-161
54. Green KJ, Goldman RD: Evidence for an interaction between the cell surface and intermediate filaments in cultured fibroblasts. Cell Motil Cytoskel 1986, 6:389-405
55. Otey CA, Pavalko FM, Burridge K: An interaction between α-actinin and β integrin subunit in vitro. J Cell Biol 1990, 111:721-729
56. Lunch RG: Differentiation and cancer. Proc Natl Acad USA 1995, 92:647-648